Grifols linked to €7bn takeover offer from Brookfield

pharmaphorum November 19, 2024
Phil Taylor

Private equity company Brookfield has reportedly moved closer to taking control of Grifols, after months of disruption at the Spanish pharma company.

A report in Spanish newspaper El Confidencial suggests that Brookfield is preparing to make a bid to take a 65% controlling stake in the drugmaker for €10.50 per share, worth around €7 billion ($7.4 billion).

That is below Grifols’ current share price of around €11, and well shy of its near-€15 share price at the start of the year, ahead of a campaign by hedge fund Gotham City Research, which claimed that the company had fraudulently manipulated its financial reporting and wiped around a third off its stock value.

Brookfield confirmed in September that it was considering a...

Today's Sponsors

Today's Sponsor